Use of antipsychotics for reducing military-related chronic PTSD symptoms does not appear effective
Patients with military-related, chronic posttraumatic stress disorder (PTSD) and symptoms that were not improved with use of an antidepressant medication did not experience a reduction in PTSD symptoms with use of the antipsychotic medication risperidone, according to a study in the August 3 issue of JAMA, a theme issue on violence and human rights. Posttraumatic stress disorder is among the most common and disabling psychiatric disorders among military personnel serving in combat. Antidepressants are the predominant pharmacotherapy for PTSD, and within the U.S. Department of Veterans Affairs (VA), 89 percent of veterans diagnosed with PTSD and treated with pharmacotherapy are prescribed serotonin reuptake inhibitors (SRIs), according to background information in the article. "However, SRIs appear to be less effective in men than in women and less effective in chronic PTSD than in acute PTSD. Thus, it may not be surprising that an SRI study in veterans produced negative results. Second-generation antipsychotics (SGAs) are commonly used medications for SRI-resistant PTSD symptoms, despite limited evidence supporting this practice," the authors write.
John H. Krystal, M.D., of the VA Connecticut Healthcare System, West Haven, Conn., and colleagues evaluated whether risperidone (a second-generation antipsychotic often used for the treatment of schizophrenia and bipolar disorder), when added to an ongoing pharmacotherapy regimen would be more effective than placebo for reducing chronic military-related PTSD symptoms among veterans whose symptoms did not respond to at least 2 adequate SRI treatments. The study consisted of a 6-month, randomized, placebo-controlled multicenter trial conducted between February 2007 and February 2010 at 23 Veterans Administration outpatient medical centers. Of the 367 patients screened, 296 were diagnosed with military-related PTSD and had ongoing symptoms despite at least 2 adequate SRI treatments, and 247 contributed to analysis of the primary outcome measure. Patients received risperidone (up to 4 mg once daily) or placebo and other psychosocial mental health therapies. Symptoms of PTSD, depression, anxiety and other health outcomes were gauged via various scales and surveys.
After analysis of the data, the researchers found no statistically significant difference between risperidone and placebo in reducing measures of PTSD symptoms after 6 months of treatment. In addition, risperidone was not statistically superior to placebo on any of the other outcomes, including improvement on measures of quality of life, depression, anxiety, or paranoia/psychosis.
Overall, the rate of adverse events during treatment was low but appeared related to dosing of risperidone.
"In summary, risperidone, the second most widely prescribed second-generation antipsychotic within VA for PTSD and the best data-supported adjunctive pharmacotherapy for PTSD, did not reduce overall PTSD severity, produce global improvement, or increase quality of life in patients with chronic SRI-resistant military-related PTSD symptoms. Overall, the data do not provide strong support for the current widespread prescription of risperidone to patients with chronic SRI-resistant military-related PTSD symptoms, and these findings should stimulate careful review of the benefits of these medications in patients with chronic PTSD," the authors conclude.
(JAMA. 2011;306:493-502. Available pre-embargo to the media at www.jamamedia.org)
Editor's Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
Editorial: Interventions for War-Related Posttraumatic Stress Disorder
In an accompanying editorial on treating military-related PTSD, Charles W. Hoge, M.D., of the Walter Reed Army Medical Center, Silver Spring, Md., writes that "significant improvements in population care for war veterans will require innovative approaches to increase treatment reach."
"Attention to the occupational context, combat physiology, and mental and physical comorbidities is essential. Validating and implementing collaborative care models based in primary care should be a high priority. Matching evidence-based components of therapy to patient preferences and reinforcing narrative processes and social connections through peer-to-peer programs are encouraged. Family members, who have their own unique perspectives, are essential participants in the veteran's healing process and also need their own support. Research is required to better understand the perceptions war veterans have concerning mental health care, acceptability of care, willingness to continue with treatment, and ways to communicate with veterans that validate their experiences as warriors."
Source: JAMA and Archives Journals
- Mental health intervention at school reduces PTSD among indonesian children affected by violenceTue, 12 Aug 2008, 16:28:25 EDT
- After traumatic event, early intervention reduces odds of PTSD in children by 73 percentWed, 29 Sep 2010, 13:17:29 EDT
- Including smoking cessation program with treatment for PTSD shows higher rate of quittingTue, 7 Dec 2010, 18:02:54 EST
- Post-deployment PTSD symptoms more common in military personnel with prior mental health disordersMon, 2 May 2011, 17:35:00 EDT
- Certain therapies appear beneficial in reducing PTSD symptoms in some trauma survivorsMon, 3 Oct 2011, 23:34:34 EDT
Articles on the same topic
- Treatment intervention for former child soldiers in Uganda associated with reducing symptoms of PTSDTue, 2 Aug 2011, 17:05:11 EDT
- Use of antipsychotics for reducing military-related chronic PTSD symptoms does not appear effectivefrom Science DailyTue, 2 Aug 2011, 22:30:35 EDT
- Treatment intervention for former child soldiers in Uganda associated with reducing symptoms of PTSDfrom Science DailyTue, 2 Aug 2011, 22:30:34 EDT
- Treatment intervention for former child soldiers in Uganda associated with reducing symptoms of PTSDfrom PhysorgTue, 2 Aug 2011, 17:00:53 EDT
- Use of antipsychotics for reducing military-related chronic PTSD symptoms does not appear effectivefrom PhysorgTue, 2 Aug 2011, 16:00:43 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- Allosaurus fed more like a falcon than a crocodile, new study finds
- Human-like opponents lead to more aggression in video game players, UConn study finds
- Origins of human culture linked to rapid climate change
- Soft matter offers new ways to study how ordered materials arrange themselves
- 14 closely related crocodiles existed around 5 million years ago
- Allosaurus fed more like a falcon than a crocodile, new study finds
- Invasive crazy ants are displacing fire ants in areas throughout southeastern US
- Beautiful 'flowers' self-assemble in a beaker
- Scientific insurgents say 'Journal Impact Factors' distort science
- GPS solution provides 3-minute tsunami alerts